When and how to analyse TP53 status (both mutations and 17p deletions) in CLL patients: the ERIC experience.

POSPÍŠILOVÁ, Šárka and Jitka MALČÍKOVÁ. When and how to analyse TP53 status (both mutations and 17p deletions) in CLL patients: the ERIC experience. In VI Simposium GCECGH, Alicante, Španělsko, květen 2016. 2016.

Basic information

• Original name: When and how to analyse TP53 status (both mutations and 17p deletions) in CLL patients: the ERIC experience.
• Authors: POSPÍŠILOVÁ, Šárka and Jitka MALČÍKOVÁ.
• Edition: VI Simposium GCECGH, Alicante, Španělsko, květen 2016, 2016.

Other information

• Type of outcome: Conference abstract
• Confidentiality degree: is not subject to a state or trade secret
• Organization unit: Central European Institute of Technology

Links

• LQ1601, research and development project: Name: CEITEC 2020 (Acronym: CEITEC2020)

Investor: Ministry of Education, Youth and Sports of the CR